JAZZ earnings
Jazz Pharmaceuticals (JAZZ) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
JAZZ earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 3, 2026 | 5.71 | 6.18 | -7.61% | $1.21B |
| Q1 2026 | May 5, 2026 | 6.34 | 4.64 | 36.64% | $1.07B |
| Q4 2025 | Feb 24, 2026 | 6.64 | 6.52 | 1.84% | $1.20B |
| Q3 2025 | Nov 5, 2025 | 8.13 | 5.95 | 36.64% | $1.13B |
| Q2 2025 | Aug 5, 2025 | -8.25 | -6.12 | -34.80% | $1.05B |
| Q1 2025 | May 6, 2025 | 1.68 | 4.51 | -62.75% | $897.84M |
| Q4 2024 | Feb 25, 2025 | 6.60 | 5.83 | 13.21% | $1.09B |
| Q3 2024 | Nov 6, 2024 | 6.61 | 5.47 | 20.84% | $1.05B |
| Q2 2024 | Jul 31, 2024 | 5.30 | 4.68 | 13.25% | $1.02B |
| Q1 2024 | May 1, 2024 | 2.68 | 4.14 | -35.27% | $901.98M |
| Q4 2023 | Feb 28, 2024 | 5.02 | 5.26 | -4.56% | $1.01B |
| Q3 2023 | Nov 8, 2023 | 4.84 | 4.90 | -1.22% | $972.14M |
| Aug 9, 2023 | 4.51 | 4.46 | 1.12% | – | |
| May 10, 2023 | 3.95 | 4.26 | -7.28% | – | |
| Mar 1, 2023 | -0.07 | 0.51 | -113.73% | – | |
| Nov 9, 2022 | 5.17 | 4.72 | 9.53% | – | |
| Aug 3, 2022 | 4.30 | 4.20 | 2.38% | – | |
| May 4, 2022 | 3.73 | 3.75 | -0.53% | – | |
| Mar 1, 2022 | 4.21 | 3.71 | 13.48% | – | |
| Nov 9, 2021 | 4.20 | 3.27 | 28.44% | – |
- JAZZ beat EPS estimates in 50 of its last 76 reports.
Updated 2026-11-03 00:59 UTC